CannabisNewsBreaks – Cannabis Global Inc. (CBGL) Announces Addition of THC to Nanotechnology Program

October 20, 2020 10:54:21

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has added tetrahydrocannabinol (“THC”) to its Project Varin research program. CBGL is conducting the program in partnership with Natural Plant Extract of California Inc (“NPE”), a licensed and regulated cannabis products manufacturer. The objective of the program is to demonstrate the cost advantages of using the company’s proprietary and provisional patent-pending nanoparticle and nanofiber technologies to change the cost model as it related to adding THC to various products. Cannabis Global filed six provisional patent applications last year, including one which outlined the methods and technologies to create new forms of polymeric cannabinoid nanoparticles. CBGl is also including  other cannabinoids, such as tetrahydrocannabivarin (“THC-V”) and cannabinol (“CBN”) in its research. The company intends to add THC to the program with the end goal of creating new particles and fibers that product formulators and manufacturers can use. “Our goal with THC and Project Varin is simple: delivering to the cannabis industry a better form of THC that is substantially more effective, less expensive, and free of the potentially dangerous chemicals used in currently available formulations,” Cannabis Global CEO Arman Tabatabaei stated in the press release. “Over the past few months, our research program has made substantial progress toward these goals with strong successes in CBD, Tetrahydrocannabivarin (‘THC-V’), and Cannabinol (‘CBN’). By applying what we have learned thus far to THC, we hope to formulate an entirely new class of THC product for the cannabis industry that will be included under our nanotechnology provisional patent filing and future patent applications.”

To view the full press release, visit

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.